New compound to fight cytomegalovirus developed
by Press Release from Outbreak News Today on (#28DD3)
A Retro94-based compound may prevent a common and sometimes fatal virus - human cytomegalovirus (CMV) - from reproducing and help to protect immunocompromised patients, such as those with HIV, on chemotherapy, with transplants, and infants from the effects of the disease, according to Penn State College of Medicine researchers. New therapies for CMV are needed, ["]
The post New compound to fight cytomegalovirus developed appeared first on Outbreak News Today.